Waldenström's macroglobulinemia surgery: Difference between revisions
No edit summary |
No edit summary |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Surgery is not the first-line treatment option for patients with waldenström's macroglobulinemia. [[Stem cell transplant]] is usually reserved for patients with either relapse or refractory | Surgery is not the first-line treatment option for patients with waldenström's macroglobulinemia. [[Stem cell transplant]] is usually reserved for patients with either relapse or refractory waldenström's macroglobulinemia.<ref name = "sure"> Waldenström's macroglobulinemia: prognosis and management. Blood Cancer Journal (2015) http://www.nature.com/bcj/journal/v5/n3/full/bcj201528a.html Accessed on November 13, 2015</ref> | ||
==Surgery== | ==Surgery== | ||
[[Stem cell transplant]] is usually reserved for patients with either relapse or refractory | [[Stem cell transplant]] is usually reserved for patients with either relapse or refractory waldenström's macroglobulinemia.<ref name = "sure"> Waldenström's macroglobulinemia: prognosis and management. Blood Cancer Journal (2015)http://www.nature.com/bcj/journal/v5/n3/full/bcj201528a.html Accessed on November 13, 2015</ref> | ||
==References== | ==References== | ||
Revision as of 05:44, 8 January 2016
|
Waldenström's macroglobulinemia Microchapters |
|
Differentiating Waldenström's macroglobulinemia from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Waldenström's macroglobulinemia surgery On the Web |
|
American Roentgen Ray Society Images of Waldenström's macroglobulinemia surgery |
|
Directions to Hospitals Treating Waldenström's macroglobulinemia |
|
Risk calculators and risk factors for Waldenström's macroglobulinemia surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Mirdula Sharma, MBBS [2]
Overview
Surgery is not the first-line treatment option for patients with waldenström's macroglobulinemia. Stem cell transplant is usually reserved for patients with either relapse or refractory waldenström's macroglobulinemia.[1]
Surgery
Stem cell transplant is usually reserved for patients with either relapse or refractory waldenström's macroglobulinemia.[1]
References
- ↑ 1.0 1.1 Waldenström's macroglobulinemia: prognosis and management. Blood Cancer Journal (2015) http://www.nature.com/bcj/journal/v5/n3/full/bcj201528a.html Accessed on November 13, 2015